Murphy Canyon Acquisition Corp.

Murphy Canyon Acquisition Corp.

MURFW
Murphy Canyon Acquisition Corp.US flagNASDAQ Global Market
0.11
USD
-0.02
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Jack Kendrick Heilbron
Sector
Financial Services
Industry
Shell Companies
Address
4995 Murphy Canyon Road San Diego CA United States of America 92123
Business
Murphy Canyon Acquisition Corp. (NASDAQ:MURFW) is a blank check company whose primary business is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with a target focus on the real estate industry including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, as well as adjacent businesses and technologies targeting the real estate space with an aggregate enterprise value of approximately $300 million to $1.2 billion. The company offers no current products or services beyond its SPAC structure and public warrants exercisable at $11.50 per share. Founded in 2021 and headquartered in San Diego, California, it operates principally in the United States. In September 2023, Murphy Canyon completed a business combination with Conduit Pharmaceuticals Limited, a clinical-stage life science company, resulting in the SPAC changing its name to Conduit Pharmaceuticals Inc. (NASDAQ:CDT), with its common stock and new warrants (CDTTW) commencing trading under those tickers while separating the original warrants (MURFW) for continued independent trading; the deal provided Conduit approximately $20 million in net proceeds after redemptions via a concurrent private placement offering of units. As of late 2025, Murphy Canyon Acquisition Corp. remains a micro-cap entity trading under its legacy ticker symbols with ongoing market activity in its warrants, reporting quarterly net losses and negative financial metrics amid a potentially inactive or delisted status for certain classes, sponsored by Presidio Property Trust which retained equity in the post-merger Conduit entity.